Affiliations of authors: Tata Memorial Centre, Parel, Mumbai, India (SSS, IM, GAM, SG, RD, RAB); Novartis Pharmaceuticals UK Limited, PharmaOps Horsham, West Sussex, UK (SS).
J Natl Cancer Inst. 2014 Mar;106(3):dju009. doi: 10.1093/jnci/dju009. Epub 2014 Feb 22.
Cervical cancer is the leading cause of cancer mortality among women in India. Because Pap smear screening is not feasible in India, we need to develop effective alternatives.
A cluster-randomized controlled study was initiated in 1998 in Mumbai, India, to investigate the efficacy of visual inspection with acetic acid (VIA) performed by primary health workers in reducing cervical cancer mortality. Four rounds of cancer education and VIA screening were conducted at 24-month intervals in the screening group, whereas cancer education was offered once at entry to the control group. The study was planned for 16 years to include four screening rounds followed by four monitoring rounds. We present results after 12 years of follow-up. Poisson regression method was used to calculate the rate ratios (RRs); two-sided χ(2) was used to calculate the probability.
We recruited 75360 women from 10 clusters in the screening group and 76178 women from 10 comparable clusters in the control group. In the screening group, we achieved 89% participation for screening and 79.4% compliance for diagnosis confirmation. The incidence of invasive cervical cancer was 26.74 per 100000 (95% confidence interval [CI] = 23.41 to 30.74) in the screening group and 27.49 per 100000 (95% CI = 23.66 to 32.09) in the control group. Compliance to treatment for invasive cancer was 86.3% in the screening group and 72.3% in the control group. The screening group showed a statistically significant 31% reduction in cervical cancer mortality (RR = 0.69; 95% CI = 0.54 to 0.88; P = .003).
VIA screening by primary health workers statistically significantly reduced cervical cancer mortality. Our study demonstrates the efficacy of an easily implementable strategy that could prevent 22000 cervical cancer deaths in India and 72600 deaths in resource-poor countries annually.
宫颈癌是印度女性癌症死亡的主要原因。由于在印度进行巴氏涂片筛查不可行,我们需要开发更有效的替代方法。
1998 年在印度孟买发起了一项集群随机对照研究,以调查初级卫生工作者进行醋酸视觉检查(VIA)在降低宫颈癌死亡率方面的效果。在筛查组中,每 24 个月进行四轮癌症教育和 VIA 筛查,而在对照组中仅在进入时提供一次癌症教育。该研究计划进行 16 年,包括四轮筛查和四轮监测。我们在随访 12 年后呈现结果。使用泊松回归法计算率比(RR);使用双侧 χ(2)计算概率。
我们从筛查组的 10 个集群中招募了 75360 名女性,从对照组的 10 个可比集群中招募了 76178 名女性。在筛查组中,我们实现了 89%的筛查参与率和 79.4%的诊断确认率。筛查组的浸润性宫颈癌发病率为每 100000 人 26.74 例(95%置信区间 [CI] = 23.41 至 30.74),对照组为每 100000 人 27.49 例(95%CI = 23.66 至 32.09)。筛查组对浸润性宫颈癌的治疗依从率为 86.3%,对照组为 72.3%。筛查组宫颈癌死亡率统计学显著降低 31%(RR = 0.69;95%CI = 0.54 至 0.88;P =.003)。
初级卫生工作者进行 VIA 筛查在统计学上显著降低了宫颈癌死亡率。我们的研究证明了一种易于实施的策略的有效性,该策略每年可在印度预防 22000 例宫颈癌死亡和资源匮乏国家的 72600 例死亡。